QA: Axsome Therapeutics Inc. in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001579428_2017_Axsome_Therapeutics_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001579428')"}

Graph

Absolute values for 0001579428, Axsome Therapeutics Inc.

  xvar xval
0 AssetsCurrent 37,999,057
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 100,730
3 remainder_Assets 112,821
4 LiabilitiesCurrent 7,170,712
5 LiabilitiesNoncurrent 9,470,445
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 6,343,648
9 ResearchAndDevelopmentExpense 21,199,860
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 341,855
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 38,212,608
1 Liabilities 16,641,157
2 Expenses 27,543,508
3 Revenues 0
4 StockholdersEquity 21,571,451
5 NetIncome -27,201,653
6 ComprehensiveNetIncome -27,201,653
7 BaseVar 41,369,564
8 EconomicCapitalRatio 0.361

Edgar->Model Mapping

Feature Distribution